Prins, Martin H.

The diagnostic odds ratio: a single indicator of test performance

Glas, A. S., Lijmer, J. G., Prins, M. H., Bonsel, G. J., & Bossuyt, P. M. M. (2003) · Journal of Clinical Epidemiology

Meta-analysis and systematic reviewsStatistical Methods in Epidemiology

Cited by 2,261

Incidence of Chronic Thromboembolic Pulmonary Hypertension after Pulmonary Embolism

Pengo, V., Lensing, A. W. A., Prins, M. H., Marchiori, A., Davidson, B. L., Tiozzo, F., Albanese, P., Biasiolo, A., Pegoraro, C., Iliceto, S., et al. (2004) · New England Journal of Medicine

Pulmonary Hypertension Research and TreatmentsVenous Thromboembolism Diagnosis and Management

Cited by 1,828

Antithrombotic Therapy for Venous Thromboembolic Disease

Büller, H. R., Agnelli, G., Hull, R. D., Hyers, T. M., Prins, M. H., & Raskob, G. E. (2004) · Chest

Venous Thromboembolism Diagnosis and ManagementBlood Coagulation and Thrombosis Mechanisms

Cited by 1,249

Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism

Weitz, J. I., Lensing, A. W. A., Prins, M. H., Bauersachs, R., Beyer-Westendorf, J., Bounameaux, H., Brighton, T. A., Cohen, A. T., Davidson, B. L., Decousus, H., et al. (2017) · New England Journal of Medicine

Venous Thromboembolism Diagnosis and ManagementBlood Coagulation and Thrombosis Mechanisms

Cited by 787

Nurse-led care vs. usual care for patients with atrial fibrillation: results of a randomized trial of integrated chronic care vs. routine clinical care in ambulatory patients with atrial fibrillation

Hendriks, J. M. L., de Wit, R., Crijns, H. J. G. M., Vrijhoef, H. J. M., Prins, M. H., Pisters, R., Pison, L. A. F. G., Blaauw, Y., & Tieleman, R. G. (2012) · European Heart Journal

Atrial Fibrillation Management and OutcomesNursing Roles and Practices

Cited by 409

A dose-ranging study evaluating once-daily oral administration of the factor Xa inhibitor rivaroxaban in the treatment of patients with acute symptomatic deep vein thrombosis: the Einstein–DVT Dose-Ranging Study

Buller, H. R., Lensing, A. W. A., Prins, M. H., Agnelli, G., Cohen, A., Gallus, A. S., Misselwitz, F., Raskob, G., Schellong, S., & Segers, A. (2008) · Blood

Venous Thromboembolism Diagnosis and ManagementBlood Coagulation and Thrombosis Mechanisms

Cited by 342

Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: systematic review and meta-analysis

Khan, F., Rahman, A., Carrier, M., Kearon, C., Weitz, J. I., Schulman, S., Couturaud, F., Eichinger, S., Kyrle, P. A., Becattini, C., et al. (2019) · BMJ

Venous Thromboembolism Diagnosis and ManagementBlood Coagulation and Thrombosis Mechanisms

Cited by 328

Efficacy and safety of the oral direct factor Xa inhibitor apixaban for symptomatic deep vein thrombosis. The Botticelli DVT dose‐ranging study

BULLER, H., DEITCHMAN, D., PRINS, M., & SEGERS, A. (2008) · Journal of Thrombosis and Haemostasis

Venous Thromboembolism Diagnosis and ManagementBlood Coagulation and Thrombosis Mechanisms

Cited by 252

Residual Thrombosis on Ultrasonography to Guide the Duration of Anticoagulation in Patients With Deep Venous Thrombosis: A Randomized Trial

Prandoni, P., Prins, M. H., Lensing, A. W. A., Ghirarduzzi, A., Ageno, W., Imberti, D., Scannapieco, G., Ambrosio, G. B., Pesavento, R., Cuppini, S., et al. (2009) · Annals of Internal Medicine

Venous Thromboembolism Diagnosis and ManagementBlood Coagulation and Thrombosis Mechanisms

Cited by 232

Recurrent venous thromboembolism and abnormal uterine bleeding with anticoagulant and hormone therapy use

Martinelli, I., Lensing, A. W. A., Middeldorp, S., Levi, M., Beyer-Westendorf, J., van Bellen, B., Bounameaux, H., Brighton, T. A., Cohen, A. T., Trajanovic, M., et al. (2016) · Blood

Venous Thromboembolism Diagnosis and ManagementBlood Coagulation and Thrombosis Mechanisms

Cited by 219

A randomized cross-over study on the effects of levonorgestrel- and desogestrel-containing oral contraceptives on the anticoagulant pathways

Tans, G., Curvers, J., Middeldorp, S., Thomassen, M. C., Prins, M., Bouma, B., Büller, H., Meijers, J., & Rosing, J. (2000) · Thrombosis and Haemostasis

Blood Coagulation and Thrombosis MechanismsVenous Thromboembolism Diagnosis and Management

Cited by 203

Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism

Middeldorp, S., Prins, M. H., & Hutten, B. A. (2014) · Cochrane Database of Systematic Reviews

Venous Thromboembolism Diagnosis and ManagementBlood Coagulation and Thrombosis Mechanisms

Cited by 133

Treatment of venous thromboembolism with vitamin K antagonists: patients' health state valuations and treatment preferences

Bossuyt, P., Stalmeier, P., Sprangers, M., van Dongen, C., Middeldorp, S., Bank, I., van der Meer, J., Hamulyák, K., Prins, M., & Locadia, M. (2004) · Thrombosis and Haemostasis

Venous Thromboembolism Diagnosis and ManagementHealth Systems, Economic Evaluations, Quality of Life

Cited by 91

Replacing Inpatient Care by Outpatient Care in the Treatment of Deep Venous Thrombosis – An Economic Evaluation

van den Belt, A., Prins, M., Gallus, A., Büller, H., Bossuyt, P., & for the TASMAN Study Group (1998) · Thrombosis and Haemostasis

Venous Thromboembolism Diagnosis and ManagementHealth Systems, Economic Evaluations, Quality of Life

Cited by 90

Patient-reported treatment satisfaction with oral rivaroxaban versus standard therapy in the treatment of acute symptomatic deep-vein thrombosis

Bamber, L., Wang, M. Y., Prins, M. H., Ciniglio, C., Bauersachs, R., Lensing, A. W. A., & Cano, S. J. (2013) · Thrombosis and Haemostasis

Venous Thromboembolism Diagnosis and ManagementPatient Satisfaction in Healthcare

Cited by 86